Products In late September 2016, the first so-called “artificial pancreas” was approved in the United States, Medtronic’s MiniMed 670G system. The system will be available by physician prescription in spring 2017. How it works The device measures glucose levels every five minutes with a sensor under the skin (subcutaneous) in tissue fluid and automatically delivers … Artificial Pancreas
Products An inhalable insulin preparation containing a rapid-acting human insulin was approved in the United States in 2014 (Afrezza, powder inhalation). The drug has not yet been registered in many countries. Pfizer’s first inhalable insulin Exubera was withdrawn from the market in 2007 for commercial reasons; see Exubera. Structure and properties Human insulin (C257H383N65O77S6, Mr … Inhalable Insulin
Products Gliclazide has been commercially available in sustained-release tablet form and approved in many countries since 1978. The sustained-release dosage forms entered the market in 2001. In addition to the original Diamicron MR, sustained-release generics have been available since 2008. Sales of the non-retarded Diamicron 80 mg were discontinued in 2012. Structure and properties Gliclazide … Gliclazide
Products Insulins are primarily commercially available in the form of clear injection solutions and turbid injection suspensions (vials, cartridges for pens, ready-to-use pens). In some countries, inhalation preparations are also available. However, these are an exception. Insulins should be stored in a refrigerator at 2 to 8°C (see under Refrigerated Storage). They must not be … Insulins
Human adenoviruses are a group of DNA viruses discovered in 1953 by Wallace P. Rowe. The U.S. cancer researcher and virologist isolated the viruses from human pharyngeal tonsils, known as adenoids. From this, the name human adenoviruses is derived for the types of viruses that affect humans. What are human adenoviruses? To date, 19 species … Human Adenoviruses: Infection, Transmission & Diseases
